Lumps, bumps and too much pain
Parents – and sometimes kids – can try to ignore what seems like a minor injury, especially if the child reports taking a fall or incurring the injury in sports. But if the lump doesn’t go away, or if the pain hurts too much or lasts too long, it’s important to follow up with a referral to assess and diagnose the reason.
Referral guidelines for a child, adolescent or young adult are simple. As a pediatrician, family practitioner or emergency department provider, look for these warning signs:
- If there is a lump, bump or pain that doesn’t go away with simple ice, rest and anti-inflammatory treatment, follow up with assessment.
- If the history of the injury doesn’t fit the pain, i.e., if the pain hurts too much or lasts too long, follow up with assessment.
- If your X-ray indicates an unusual swelling or lump, refer for additional assessment. And even if the x-ray is not indicating a reason for the lump, bump or pain, referral for assessment is warranted.
Our experience makes a difference
The physicians in our pediatric bone and soft tissue cancer program (sarcoma) have an exceptional depth of clinical experience because we see a high volume of patients with bone and muscle tumors. When you refer your patient directly here, he or she gets the benefit of our coordinated, comprehensive diagnosis and treatment, instead of receiving fractured treatment from a variety of sites.
- We’re the only facility in the 13-county Twin Cities metro area that operates on pediatric bone and muscle tumors.
- University of Minnesota Amplatz Children’s Hospital led a national rhabdomyosarcoma trial that demonstrated a 20 percent improvement in survival for the highest-risk patients.
- Physicians at University of Minnesota Amplatz Children’s Hospital and University of Minnesota Medical Center, Fairview see more than 70% of all sarcomas, regardless of the age group, in the 13-county Twin Cities metro area.
- The University of Minnesota houses 26 faculty members across nine departments working on preclinical to translational/Phase 1 clinical trial research related to bone and soft-tissue cancer.
- University of Minnesota Amplatz Children’s Hospital enrolled more patients with osteosarcoma in the current international trial than any other hospital in the nation.
Soft tissue and bone cancers we treat include:
- Ewing sarcoma
- Synovial sarcoma
- Other tumors
An entire team dedicated to treating your patient
From biopsies to treatment, University of Minnesota Amplatz Children’s Hospital offers dedicated practitioners, the latest technology and a healing environment. Our experts collaborate to provide a personalized treatment plan for your patient, which might consist of radiation therapy, chemotherapy, surgery, stem-cell therapy or combination therapy. We’ve received national recognition for our successful limb-salvage procedures.
Our multidisciplinary team includes pediatric oncologists, orthopedic surgeons, radiation oncologists, pathologists, physical therapists, oncology nurse practitioners and others. We meet regularly as a group to draw on the team’s extensive experience to ensure that patients receive individualized treatment plans ideal for their conditions. We are constantly improving treatment for patients with musculoskeletal tumors through coordinated advances in laboratory work, clinical research and education.
Our orthopedic oncologists use their expertise to apply emerging technology and therapies, and gain insights that will lead to better function and quality of life for patients with bone and muscle tumors. For patients that require radiation and chemo, our Survivorship program provides seamless follow up of orthopedic as well as other issues.
With the goal of achieving optimal outcomes in treating bone and soft tissue tumors, the care team at University of Minnesota Amplatz Children’s Hospital is proud to serve as a resource to referring physicians and their patients. Please don’t hesitate to contact us at 888-KIDS-UMN (888-543-7866).
Brenda Weigel, MD, MSc, Associate Professor and Division Head, Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Minnesota